Medindia

X

Experimental Drug Deals Effectively with Prostate Cancer Cells

by Medindia Content Team on  August 15, 2006 at 10:13 AM Drug News   - G J E 4
Experimental Drug Deals Effectively with Prostate Cancer Cells
An experimental RNA-based drug acts by using genetic material called targeting RNA, to enter cancer cells, and another type, called silencing RNA , to stop the expression of a protein that keeps the cells alive, thereby destroying prostate cancer cells leaving normal cells unharmed.
Advertisement

The drug, developed at Duke University Medical Center, uses one type of genetic material, called In tests in mice with prostate cancer, the drug shrank the size of their tumors by half, while the tumors in control mice that did not receive the drug continued to grow, said study co-author Bruce Sullenger, Ph.D., director of Duke's Translational Research Institute and chief of the Division of Experimental Surgery.

Advertisement
The mice showed no side effects from the treatment, Sullenger said.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All